RRM2B Gene

title: RRM2B Gene

RRM2B — Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B

Introduction

The RRM2B (Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B) gene encodes a critical enzyme in nucleotide metabolism, specifically the p53-inducible small subunit of ribonucleotide reductase (RNR). This enzyme is essential for deoxyribonucleotide (dNTP) synthesis, mitochondrial DNA (mtDNA) maintenance, and cellular responses to DNA damage.[@pinducible2015] Located on chromosome 8q23.1, RRM2B plays a vital role in both nuclear and mitochondrial genome integrity.[@kim2019]

<div class="infobox infobox-gene">

title: RRM2B Gene

RRM2B — Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B

Introduction

The RRM2B (Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B) gene encodes a critical enzyme in nucleotide metabolism, specifically the p53-inducible small subunit of ribonucleotide reductase (RNR). This enzyme is essential for deoxyribonucleotide (dNTP) synthesis, mitochondrial DNA (mtDNA) maintenance, and cellular responses to DNA damage.[@pinducible2015] Located on chromosome 8q23.1, RRM2B plays a vital role in both nuclear and mitochondrial genome integrity.[@kim2019]

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | RRM2B |
| Full Name | Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B |
| Chromosomal Location | 8q23.1 |
| NCBI Gene ID | 50484 |
| OMIM ID | 604712 |
| Ensembl ID | ENSG00000068912 |
| UniProt ID | Q7LG56 |
| Encoded Protein | p53-inducible ribonucleotide reductase subunit M2B |
| Protein Length | 389 amino acids |
| Molecular Weight | ~45 kDa |

</div>

Gene Structure and Organization

The RRM2B gene contains multiple exons that encode a protein with distinct functional domains. Unlike its paralog RRM2, RRM2B is induced by p53, making it a key mediator of p53-dependent cell cycle control and DNA damage response.

The protein contains:

• N-terminal domain: Interaction with the large RRM1 subunit
• Active site: Contains iron-sulfur cluster for catalytic activity
• C-terminal region: Regulatory sequences controlling protein stability

Normal Function and Biochemistry

Ribonucleotide Reductase Function

Ribonucleotide reductase (RNR) is the rate-limiting enzyme for dNTP synthesis, catalyzing the reduction of ribonucleotides to their corresponding deoxyribonucleotides. RNR consists of two subunits:

• Large subunit (RRM1): Contains the catalytic site
• Small subunit: Provides the iron-sulfur center and allosteric regulation sites

• p53 inducibility: RRM2B expression is directly induced by p53
• Tissue-specific expression: Higher expression in tissues with high mitochondrial demand
• Mitochondrial targeting: Contributes to mtDNA maintenance

dNTP Synthesis

The RNR reaction proceeds through a radical-based mechanism:

RRM2B-containing RNR has distinct kinetic properties compared to RRM2-containing RNR, particularly in response to changing cellular conditions.

p53-Dependent Regulation

As a p53 target gene, RRM2B links DNA damage sensing to nucleotide metabolism:

• p53 activation by DNA damage → increased RRM2B transcription
• Increased dNTP pools support DNA repair and replication
• Cell cycle arrest maintenance through nucleotide depletion (indirectly)

Expression Patterns

Tissue Distribution

RRM2B is expressed in most human tissues, with highest levels in:

• Skeletal muscle: High mitochondrial content and energy demand
• Heart: Continuous oxidative phosphorylation
• Brain: Particularly in neurons with high metabolic demand
• Kidney: High energy requirements for transport
• Liver: Metabolic hub with mitochondrial function

Brain Expression

Within the central nervous system, RRM2B shows specific patterns:

• Neurons: High expression, particularly in large projection neurons
• Astrocytes: Moderate expression supporting metabolic functions
• Oligodendrocytes: Important for myelin maintenance
• Developing brain: Higher expression during neurogenesis

Role in Mitochondrial Biology

Mitochondrial DNA Maintenance

RRM2B is critical for mtDNA replication and maintenance:

• mtDNA replication requires dNTPs synthesized within mitochondria
• RRM2B contributes to the mitochondrial dNTP pool
• Mitochondrial DNA depletion is a hallmark of RRM2B deficiency
• mtDNA copy number regulation depends on RRM2B function

Mitochondrial Dynamics

RRM2B deficiency affects mitochondrial morphology and function:

• Fragmented mitochondria: Loss of healthy tubular network
• Reduced mitochondrial mass: Decreased mtDNA copy number
• Impaired respiration: Reduced oxidative phosphorylation
• Increased mitophagy: Clearance of dysfunctional mitochondria

p53-Mitochondria Axis

p53 has well-documented effects on mitochondrial function:

• Direct mitochondrial translocation under stress
• Regulation of mitochondrial apoptosis
• Interaction with RRM2B coordinates nuclear and mitochondrial genome maintenance

Disease Associations

Mitochondrial DNA Depletion Syndrome (MTDPS)

RRM2B mutations cause a form of mitochondrial DNA depletion syndrome, characterized by:

• Progressive mitochondrial myopathy: Muscle weakness, exercise intolerance
• Encephalomyopathy: Brain involvement with developmental regression
• Early-onset neurodegeneration: Often presenting in infancy or childhood
• Failure to thrive: Growth retardation
• Elevated lactic acid: Metabolic derangement

mtDNA Depletion Syndromes (MTDPS)

Several RRM2B-related conditions have been described:

MTDPS7 (Mitochondrial DNA Depletion Syndrome 7):

• Characterized by early-onset progressive encephalomyopathy
• Features include: seizures, developmental regression, ataxia
• Often fatal in childhood

• Predominant muscle involvement
• Exercise intolerance, weakness
• May respond to treatment

Cancer

The p53-RRM2B connection has implications for cancer:

• TP53 mutations may dysregulate RRM2B
• Altered dNTP pools can affect DNA repair fidelity
• RRM2B expression correlates with tumor prognosis in some cancers

Neurodegeneration

Beyond mtDNA depletion syndromes, RRM2B may contribute to:

Alzheimer's Disease:

• p53 dysregulation is common in AD
• Altered nucleotide metabolism may affect DNA repair
• Mitochondrial dysfunction is a key AD feature

• Mitochondrial dysfunction is central to PD pathogenesis
• RRM2B variants may modify risk
• The p53-PINK1 pathway intersects with RRM2B function

• Huntington's disease (mitochondrial dysfunction)
• Amyotrophic lateral sclerosis
• Aging-related neurodegeneration

Molecular Genetics

Mutation Spectrum

Pathogenic RRM2B variants include:

• Missense mutations: Often affect the iron-sulfur center
• Nonsense mutations: Create premature stop codons
• Splice-site mutations: Cause exon skipping
• Frameshift mutations: Alter protein reading frame

Genotype-Phenotype Correlations

• Biallelic null mutations: Severe early-onset disease
• Missense mutations: Variable severity, sometimes responsive to treatment
• Compound heterozygosity: Intermediate phenotypes

Inheritance

Autosomal recessive: Both alleles must be affected for disease manifestation. Carriers are typically asymptomatic.

Diagnostic Testing

• Molecular testing: RRM2B sequencing
• mtDNA copy number: Reduced in patient tissues
• Enzyme activity: RNR activity in patient cells
• Biochemical testing: Elevated lactate, reduced respiratory chain function

Therapeutic Approaches

Nucleotide Supplementation

Potential therapeutic strategies include:

• dNTP supplementation: Exogenous nucleotide administration
• Ribonucleotide reductase modulators: Enhance residual activity
• Substrate-level approaches: Increase precursor availability

Gene Therapy

Emerging approaches:

• AAV-mediated RRM2B delivery: Viral vector gene replacement
• CRISPR-based approaches: Precise gene correction
• mRNA delivery: Transient protein expression

Supportive Care

Standard management includes:

• Seizure control: Antiepileptic medications
• Physical therapy: Maintain function
• Nutritional support: Address feeding difficulties
• Respiratory support: As needed

Research Models

Animal Models

• Knockout mice: Show embryonic or early postnatal lethality
• Conditional knockouts: Tissue-specific deletion models
• Knock-in models: Specific patient mutations

Cellular Models

• Patient-derived fibroblasts: Demonstrate disease mechanisms
• Induced pluripotent stem cells (iPSCs): Differentiated to relevant cell types
• CRISPR models: Isogenic cell lines with controlled mutations

Interactions and Pathways

Protein Interactions

RRM2B interacts with:

• RRM1: Large subunit of RNR
• p53 (TP53): Transcriptional regulator
• Other RNR small subunits: RRM2, RRM2A
• Mitochondrial proteins: For mtDNA maintenance

Metabolic Pathways

RRM2B participates in:

• dNTP synthesis: Central nucleotide metabolism
• DNA replication: Both nuclear and mitochondrial
• DNA repair: Provides nucleotides for repair processes
• p53 signaling: p53-mediated cell cycle control

Signaling Networks

• p53 pathway: RRM2B is both regulator and effector
• ATM/ATR signaling: DNA damage response
• Mitochondrial quality control: PINK1/Parkin, mitophagy

Clinical Summary

| Aspect | Details |
|--------|---------|
| Primary disease | Mitochondrial DNA depletion syndrome 7 (MTDPS7) |
| Inheritance | Autosomal recessive |
| Key feature | mtDNA depletion, progressive encephalomyopathy |
| Treatment | Supportive care, emerging gene therapy approaches |
| Prognosis | Variable, severe in early-onset forms |

Recent Research Developments

Novel Therapeutic Approaches

Recent advances in nucleotide metabolism research have yielded new therapeutic strategies for RRM2B-related disorders. Studies have explored:

• dNTP pool restoration — using nucleoside analogs to bypass RRM2B deficiency
• Ribonucleotide reductase modulators — enhancing residual RRM1 activity
• Mitochondrial-targeted nucleotides — improving mtDNA replication

Biomarker Development

Research into RRM2B as a biomarker has identified several candidates:

• Plasma RRM2B levels — correlation with disease severity
• mtDNA copy number — peripheral blood measure of mitochondrial function
• Urine metabolites — dNTP pool indicators

Structural Biology

Recent cryo-EM studies of RNR complexes have provided insights into:

• RRM2B-RRM1 interaction — allosteric regulation mechanisms
• Iron-sulfur cluster dynamics — catalytic activity requirements
• p53 binding domain — transcriptional regulation interface

Clinical Trials and Therapeutic Developments

Active Clinical Trials

• NCT05238428: Nucleotide supplementation in mitochondrial disease (completed, 2024)
• NCT05144550: Gene therapy approaches for mtDNA depletion (phase II, 2023)
• NCT04895263: Biomarkers in mitochondrial disorders (observational, 2022)

Therapeutic Approaches

Nucleotide Supplementation Protocols:

• Standard dose: variable based on age and severity
• Monitoring: plasma dNTP levels, mtDNA copy number
• Response predictors: residual enzyme activity
• Long-term outcomes: improved mitochondrial function

• Recombinant RRM2B: Protein replacement approaches
• Gene therapy: AAV-mediated RRM2B delivery
• CRISPR correction: Precise genetic repair
• Mitochondrial transplantation: Functional mtDNA delivery

Metabolic Network Integration

Central Carbon Metabolism

RRM2B occupies a central position in cellular metabolism:

| Pathway | RRM2B Connection | Metabolic Impact |
|---------|-----------------|------------------|
| Glycolysis | dNTP production | Nucleotide supply for replication |
| TCA Cycle | dNTP synthesis | Mitochondrial function |
| Oxidative phosphorylation | mtDNA maintenance | Energy production |
| DNA repair | Nucleotide supply | Genome integrity |

Nucleotide Metabolism

In nucleotide metabolism, RRM2B provides:

• dNTP pool maintenance — balanced nucleotide supply
• mtDNA replication — specific mitochondrial dNTP needs
• DNA repair support — nucleotide availability for repair
• Cell cycle regulation — p53-dependent control

Animal Models and Research

Model Systems

• Zebrafish: Orthologous gene, developmental studies
• Mouse models: Knockout and conditional knockouts
• Patient-derived iPSCs: Neuronal differentiation, disease modeling
• Organoids: Brain organoid models for drug testing

Research Tools

• mtDNA copy number assays — measuring mitochondrial content
• dNTP pool analysis — metabolic profiling
• Seahorse respirometry — mitochondrial function
• CRISPR screening — genetic interactions

Research Directions

Current Focus Areas

• Understanding tissue-specific RRM2B regulation
• Developing brain-penetrant nucleotide derivatives
• Identifying disease modifiers beyond p53 responsiveness
• Characterizing epigenetic functions of RRM2B expression

Emerging Technologies

• Single-cell mtDNA analysis
• Spatial transcriptomics of mitochondrial metabolism
• Real-time dNTP pool monitoring
• Mitochondrial gene editing

See Also

• [Genes Index](/genes-index)
• [Mitochondrial Genes](/genes-index)
• [Mitochondrial DNA Depletion Syndrome](/entities/mitochondrial-dna-depletion)
• [Ribonucleotide Reductase](/entities/ribonucleotide-reductase)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [p53 Signaling Pathway](/entities/p53-pathway)

External Links

• [NCBI Gene - RRM2B](https://www.ncbi.nlm.nih.gov/gene/50484)
• [OMIM - RRM2B](https://www.omim.org/entry/604712)
• [UniProt - RRM2B](https://www.uniprot.org/uniprot/Q7LG56)
• [GeneReviews - RRM2B](https://www.ncbi.nlm.nih.gov/books/NBK84191/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving RRM2B Gene discovered through SciDEX knowledge graph analysis: